The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy

Withdrawn before enrolling · Phase 4

Conditions studied: Hypertension

In brief

This is a single-arm, open label safety and dose titration study evaluating the use of Clevidipine to rapidly control elevated blood pressure in patients who have an Intracranial Pressure Monitoring device.

Key facts

Study ID

NCT01910532

Run by

Mario Ammirati

People needed

0

Starts

2010-04-01

Expected to finish

2012-11-01

Last updated by the study team

2013-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female, 18 years or older
• Written informed consent from the patient or their legal representative family member before initiation of any study-related procedures
• Patients who clinically require Intracranial Pressure Monitoring device
• Patients who have baseline systolic blood pressure (SBP) (immediately prior to initiation of Clevidipine) > 160 mmHg measured using an arterial line
• Patients who required IV antihypertensive therapy to achieve SBP ≤ 160 mm Hg

You may not qualify if…

• Patients who are prisoners
• Patients who received an oral antihypertensive medication within 2 hours prior to initiation of Clevidipine
• Patients who received any other IV antihypertensive medication within 2 hours prior to initiation of Clevidipine
• Patients who have fixed dilated pupils and/or absence of gag and oculo-cephalic brain stem reflexes
• Patients with a history of allergy or intolerance to calcium channel blockers
• Patients with a history of allergy to soybean oil or egg lecithin
• Patients who have participated or are currently participating in a clinical trial of an investigational drug within 30 days prior to enrollment
• Patients who have acute myocardial infarction (AIM) on presentation
• Patients who have known or suspected aortic dissection
• Females who are pregnant or are breastfeeding
• Patients with a history of liver failure, cirrhosis or pancreatitis
• Patients with a prior directive against advanced life support
• Patients with a history of impaired lipid metabolism
• Patients with a history of severe aortic stenosis

Where it is running

• The Ohio State University Medical Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.